Human oral mucosal keratinocytes (HOK; ScienCell Research Lab, Carlsbad, CA, USA) were cultured until subconfluent. Trypsin LE express (GIBCO Invitrogen Life Technologies, Grand Island, NY, USA) was used to detach the cells from the culture flask into suspension. The cell suspension was then centrifuged and the supernatant removed. The cells were then resuspended in keratinocyte culture medium and seeded at an initial cell density of 1 × 105 cells/mL into 12-well culture inserts (Falcon, Corning, NY, USA) with mitomycin C (MMC)-treated 3T3-J2 feeder cells in keratinocyte culture medium (KCM), separated by the cell culture insert permeable membrane. KCM comprises Dulbecco's modified Eagle's medium (DMEM/F12 [3:1]) supplemented with 10% fetal bovine serum (GIBCO Invitrogen Life Technologies), 1% L-Glutamine (GIBCO Invitrogen Life Technologies), 5 μg/mL insulin (novolin; Novartis Pharmaceuticals, Tokyo, Japan), 1% penicillin-streptomycin (Meiji Seika, Tokyo, Japan), 0.4 μg/mL hydrocortisone (saxizon; Kowa, Tokyo, Japan), 2 nM triiodothyronine (T3; Sigma Aldrich, Tokyo, Japan), 1 nM cholera toxin (List Biological Laboratories, Inc., Campbell, CA, USA), and 10 ng/mL EGF (Higeta Shoyu, Tokyo, Japan). Incubation was carried out at 37°C and 5% CO2. All procedures were carried out following the formation of mature, stratified epithelial cell sheets.